Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Technology
3.2. Snippet by Product
3.3. Snippet by Therapeutic Area
3.4. Snippet by Application
3.5. Snippet by End User
3.6. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising demand for radiation-free devices in oncology
4.1.1.2. Technological Advancements in Optical Imaging
4.1.2. Restraints
4.1.2.1. Shortage of skilled operators in the Global Optical Imaging Market
4.1.3. Opportunity
4.1.3.1. Emerging Technologies
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Technology
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
7.1.2. Market Attractiveness Index, By Technology
7.2. Optical Coherence Tomography (OCT)*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Endoscopy
7.4. Photoacoustic imaging
7.5. Diffused optical tomography (DOT)
7.6. Raman Spectroscopy
7.7. Super-resolution microscopy
7.8. Others
8. By Product
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
8.1.2. Market Attractiveness Index, By Product
8.2. Imaging System *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Illumination System
8.4. Software
8.5. Lenses
8.6. Camera
9. By Therapeutic Area
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
9.1.2. Market Attractiveness Index, By Therapeutic Area
9.2. Ophthalmology *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Oncology
9.4. Neurology
9.5. Cardiology
9.6. Dermatology
9.7. Others
10. By Application
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Pathological Imaging *
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Intra-Operative Imaging
10.4. Others
11. By End User
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals/Clinics *
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Diagnostic Imaging Centres
11.4. Research Laboratories
11.5. Others
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. U.K.
12.3.8.3. France
12.3.8.4. Spain
12.3.8.5. Italy
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. Company Profiles
14.1. Abbott Laboratories*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Carl-Zeiss AG
14.3. Canon Inc.
14.4. Danaher Corporation
14.5. Koninklijke Philips N.V.
14.6. PerkinElmer Inc.
14.7. Topcon Healthcare
14.8. Leica Microsystems
14.9. Visionix
14.10. Cylite Pty Ltd
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us